Literature DB >> 11550734

Rationally and empirically derived dimensions of children's symptomatology: expert ratings and confirmatory factor analyses of the CBCL.

L J Lengua1, C A Sadowski, W N Friedrich, J Fisher.   

Abstract

Expert ratings and confirmatory factor analyses were used to develop an alternative system for scoring the Child Behavior Checklist (CBCL; T. M. Achenbach, 1991) to measure specific dimensions corresponding to current conceptualizations of child symptomatology. Data were from a nonclinic and 2 independent clinic samples. Subscales measuring Anxiety, Attention Problems/Hyperactivity, Conduct Problems, Depression, Oppositional Defiant, Social Problems/Immaturity, and Somatization were created. Logistic regressions were conducted to evaluate the diagnostic efficiency and discrimination of the new and original approaches to scoring the CBCL. Some of the new subscales demonstrated better sensitivity, positive predictive power, and discriminant validity than the original CBCL subscales; however, subscales from both approaches demonstrated low sensitivity. Results support the use of the new subscales for specific research purposes.

Entities:  

Mesh:

Year:  2001        PMID: 11550734

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  52 in total

1.  Who are the comorbid adolescents? Agreement between psychiatric diagnosis, youth, parent, and teacher report.

Authors:  Eric A Youngstrom; Robert L Findling; Joseph R Calabrese
Journal:  J Abnorm Child Psychol       Date:  2003-06

2.  Association between depressive symptoms and negative dependent life events from late childhood to adolescence.

Authors:  Daniel P Johnson; Mark A Whisman; Robin P Corley; John K Hewitt; Soo Hyun Rhee
Journal:  J Abnorm Child Psychol       Date:  2012-11

3.  Linking substance use and problem behavior across three generations.

Authors:  Jennifer A Bailey; Karl G Hill; Sabrina Oesterle; J David Hawkins
Journal:  J Abnorm Child Psychol       Date:  2006-06-03

4.  Longitudinal associations among youth depressive symptoms, peer victimization, and low peer acceptance: an interpersonal process perspective.

Authors:  Karen P Kochel; Gary W Ladd; Karen D Rudolph
Journal:  Child Dev       Date:  2012-02-07

5.  Predicting depressive and anxiety disorders with the YASR internalising scales (empirical and DSM-oriented).

Authors:  Kaeleen Dingle; Alexandra Clavarino; Gail M Williams; William Bor; Jake M Najman; Rosa Alati
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-10-26       Impact factor: 4.328

6.  Trajectories of marijuana use from adolescence into adulthood: Environmental and individual correlates.

Authors:  Marina Epstein; Karl G Hill; Alyssa M Nevell; Katarina Guttmannova; Jennifer A Bailey; Robert D Abbott; Rick Kosterman; J David Hawkins
Journal:  Dev Psychol       Date:  2015-09-21

7.  Social and generalized anxiety symptoms and alcohol and cigarette use in early adolescence: the moderating role of perceived peer norms.

Authors:  Jennifer M Zehe; Craig R Colder; Jennifer P Read; William F Wieczorek; Liliana J Lengua
Journal:  Addict Behav       Date:  2012-12-13       Impact factor: 3.913

8.  Diagnostic efficiency of the CBCL thought problems and DSM-oriented psychotic symptoms scales for pediatric psychotic symptoms.

Authors:  Stephanie Salcedo; Sabeen H Rizvi; Lindsey K Freeman; Jennifer K Youngstrom; Robert L Findling; Eric A Youngstrom
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-03-20       Impact factor: 4.785

9.  Parenting as a Moderator of the Effects of Maternal Depressive Symptoms on Preadolescent Adjustment.

Authors:  Maureen Zalewski; Stephanie F Thompson; Liliana J Lengua
Journal:  J Clin Child Adolesc Psychol       Date:  2015-04-27

10.  Alcohol and tobacco use disorder comorbidity in young adults and the influence of romantic partner environments.

Authors:  Meredith C Meacham; Jennifer A Bailey; Karl G Hill; Marina Epstein; J David Hawkins
Journal:  Drug Alcohol Depend       Date:  2013-02-19       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.